GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theralase Technologies Inc (OTCPK:TLTFF) » Definitions » FCF Yield %

Theralase Technologies (Theralase Technologies) FCF Yield % : -6.21 (As of May. 26, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Theralase Technologies FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Theralase Technologies's Trailing 12-Month Free Cash Flow is $-1.76 Mil, and Market Cap is $27.88 Mil. Therefore, Theralase Technologies's FCF Yield % for today is -6.21%.

The historical rank and industry rank for Theralase Technologies's FCF Yield % or its related term are showing as below:

TLTFF' s FCF Yield % Range Over the Past 10 Years
Min: -30.27   Med: -10.03   Max: -0.11
Current: -6.21


During the past 13 years, the highest FCF Yield % of Theralase Technologies was -0.11%. The lowest was -30.27%. And the median was -10.03%.

TLTFF's FCF Yield % is ranked worse than
57.59% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: -2.815 vs TLTFF: -6.21

Theralase Technologies's FCF Margin % for the quarter that ended in Dec. 2023 was -345.76%.


Theralase Technologies FCF Yield % Historical Data

The historical data trend for Theralase Technologies's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theralase Technologies FCF Yield % Chart

Theralase Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.05 -11.92 -5.52 -7.09 -9.86

Theralase Technologies Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.80 -6.22 -7.54 - -12.06

Competitive Comparison of Theralase Technologies's FCF Yield %

For the Medical Devices subindustry, Theralase Technologies's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theralase Technologies's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Theralase Technologies's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Theralase Technologies's FCF Yield % falls into.



Theralase Technologies FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Theralase Technologies's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-3.064 / 31.070696
=-9.86%

Theralase Technologies's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.937 * 4 / 31.070696
=-12.06%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Theralase Technologies FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Theralase Technologies FCF Yield % Related Terms

Thank you for viewing the detailed overview of Theralase Technologies's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Theralase Technologies (Theralase Technologies) Business Description

Traded in Other Exchanges
Address
41 Hollinger Road, Toronto, ON, CAN, M4B 3G4
Theralase Technologies Inc is a clinical-stage pharmaceutical company. It is dedicated to the research and development of light-activated Photo Dynamic Compounds, their associated drug formulations, and technology platforms intended to safely and effectively; treat various cancers, bacteria, and viruses. The Cool Laser Technology division designs, develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the FDA for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle, and joint conditions. The ACT division conducts preclinical and clinical research and development for PDCs, in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them.